Multiple Dose Escalation Study In Medically Stable Subjects With Psoriasis
Status:
Completed
Trial end date:
2004-04-01
Target enrollment:
Participant gender:
Summary
This study was conducted in subjects with psoriasis to evaluate drug activity in this patient
population by analysis of changes in psoriatic lesion biopsy characteristics. This subject
population was selected to evaluate potentially relevant biological activity of CP-690,550 as
well as assessing safety and pharmacokinetics.